PubMed · 1269876
Piperazine hepatitis.
Abstract
The first reported case of piperazine toxicity resembling viral hepatitis is described in a 25-year-old woman. The illness, which was severe, occurred after administration of the drug on two separate occasions. The evidence favors a hypersensitivity mechanism rather than a direct toxic effect of piperazine or its metabolites on the liver. The humoral or cellular immune basis for such hypersensitivity has not been elucidated.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
A N Hamlyn, J S Morris, I Sarkany, S Sherlock. 1976. Piperazine hepatitis.. https://pubmed.ncbi.nlm.nih.gov/1269876/
Cite the original work for its findings. Save a collection to share your selection of sources.